ANIP - ANI Pharmaceuticals, Inc. Quarterly EPS earnings growth
Volatility in the ANI Pharmaceuticals (ANIP) share price is evident through the current quarterly EPS growth rate, although its reputation as a reliable supplier of niche generics supports the asset. Stability is driven by eco-friendly drug synthesis and skilled management that balances the mass market with orphan products. Meanwhile, the 33.50 metric confirms the current level, helping investors timely assess operational drawdowns and avoid a value trap.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwhdatcg.m7-7dqbc3k&start=20220704&end=20261115&filename=GURU_Markets_-_ANIP_-_ANI-Pharmaceuticals_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "anipharmaceuticals.com (ANIP): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 11/15/2026 | 👁️GURU.Markets👁️")
Comprehensive metric breakdowns and analytics for ANI Pharmaceuticals (ANIP)
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Debt to Equity ANI Pharmaceuticals|ANIP - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital ANI Pharmaceuticals Inc|ANIP - Company Total Debt Obligations|Debt to Book Value ANI Pharmaceuticals, Inc.|ANIP - Company Long-Term Loans and Borrowings|Company Short-Term Debt ANI Pharmaceuticals|Quick Ratio anipharmaceuticals.com
- earnings and market multiples details:
ANIP - Final Profit|Projected Future Earnings ANI Pharmaceuticals|ANIP - P/E Multiple|Future Price to Earnings ANI Pharmaceuticals|ANIP - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ANI Pharmaceuticals, Inc.|ANIP - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) ANI Pharmaceuticals|ANIP - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth anipharmaceuticals.com|ANIP - Net earnings per share growth this year|Earnings growth forecast for next year ANI Pharmaceuticals
- sales revenue and business income indicators:
Analysis of all company metrics:ANI Pharma, ANIP
Portfolio managers require objective verification of capital efficiency through net earnings per share dynamics. This metric measures actual quarterly operational margins, accounting for the impact of the tax regime on bottom-line income. By analyzing shifts in quarterly EPS levels, investors assess the speed at which quotes adapt to regulatory changes. For ANI Pharmaceuticals (ANIP), this indicator reflects the scaling effect of its generics portfolio. Expanding distribution optimizes fixed costs, thereby strengthening the company's operating leverage.
Who ANI Pharmaceuticals competes with
HLN: Quarterly EPS earnings growth|Kenvue Corp - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma PLC) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months jyongbio.com MENS|Year-over-year earnings per share growth for the last twelve months Ligand (LGND)|AMRX (Amneal) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|Quarterly EPS earnings growth Alvotech Biopharmaceuticals ALVO|liquidia.com - Quarterly EPS earnings growth|GLPG - Quarterly EPS earnings growth|MannKind Corp. (MNKD) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Corp) - Quarterly EPS earnings growth|SPRY: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth TBPH|Year-over-year net earnings per share change for the last twelve months Aquestive Therapeutics, Inc.|Year-over-year earnings per share growth for the last twelve months scPharmaceuticals Inc. SCPH|TECX: Year-over-year earnings per share growth for the last 12 months|TNXP - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months SXT Pharmaceuticals SXTC|EPRX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months bioharvest.com (BHST)|Year-over-year net earnings per share growth for the last 12 months EXOZ|ORMP: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Entera Bio Ltd. (ENTX)|HYFT (MindWalk Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ABVC (ABVC BioPharma, Inc)|Year-over-year earnings per one share growth for the last 12 months CPIX|QNTM - Year-over-year earnings per share growth for the last twelve months|FibroGen Corp (FGEN) - Year-over-year net earnings per share growth for the last 12 months|Telomir Pharmaceuticals Corp (TELO) - Year-over-year earnings per share growth for the last twelve months|Rani Therapeutics (RANI) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Synergy CHC Corp.|Earnings per share growth in annualized terms for the last twelve months rallybio.com RLYB|Quarterly EPS earnings growth LEXX|PULM: Year-over-year net earnings per share trend for the last twelve months|Pheton Holdings Ltd - Year-over-year net earnings per share growth for the last 12 months|APM - Year-over-year net earnings per share growth for the last 12 months|LYRA - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. (TNFA) - Year-over-year earnings per share growth for the last twelve months|cbdMD Corp - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months PRFX|Altamira Therapeutics (CYTO) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth LIPO|Quarterly EPS earnings growth optinose.com (OPTN)|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals, Inc. PIRS|Procaps (PROC) - Earnings per share growth in annualized terms for the last twelve months|PTPI - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Qilian International Corp QLI|SLRN: Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TFFP (tffpharma.com)
